Undercover: Gene control by metabolites and metabolic enzymes

Genes and Development

Volumn 30, Issue 21, 2016, Pages 2345-2369

  van der Knaap, Jan A ^a   Verrijzer, C Peter ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Chromatin; Development; Epigenetics; Metabolism; Transcription

Indexed keywords

ACETYL COENZYME A; ENZYME; FRUCTOSE BISPHOSPHATASE; HISTONE; METABOLIC ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEOTIDE; SIRTUIN; UNCLASSIFIED DRUG; CHROMATIN;

ACETYLATION; ACYLATION; CANCER CELL; CELL DIFFERENTIATION; CHROMATIN; CHROMATIN STRUCTURE; DEACETYLATION; DEMETHYLATION; DEVELOPMENT; DIET; DISEASES; DONOR; DYNAMICS; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; INHERITANCE; METABOLISM; METABOLITE; METHYLATION; NONHUMAN; NUTRIENT AVAILABILITY; PRIORITY JOURNAL; REVIEW; SENSOR; STEM CELL; ANIMAL; BIOSYNTHESIS; CELL NUCLEUS; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; NEOPLASM; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL;

ACETYL COENZYME A; ANIMALS; CELL NUCLEUS; CHROMATIN; GENE EXPRESSION REGULATION; HISTONES; HUMANS; METABOLISM; NAD; NEOPLASMS; PLURIPOTENT STEM CELLS;

EID: 84996940048     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.289140.116     Document Type: Review

References (212)

1. Aird KM, Zhang G, Li H, Tu Z, Bitler BG, Garipov A, Wu H, Wei Z, Wagner SN, Herlyn M, et al. 2013. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep 3: 1252-1265.
2. Allis CD, Jenuwein T. 2016. The molecular hallmarks of epigenetic control. Nat Rev Genet 17: 487-500.
3. Altenberg B, Greulich KO. 2004. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84: 1014-1020.
4. Ariyannur PS, Moffett JR, Madhavarao CN, Arun P, Vishnu N, Jacobowitz DM, Hallows WC, Denu JM, Namboodiri AM. 2010. Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain. J CompNeurol 518: 2952-2977.
5. Bai P, Cantó C, Oudart H, Brunyánszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, et al. 2011. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13: 461-468.
6. Barbosa MT, Soares SM, Novak CM, Sinclair D, Levine JA, Aksoy P, Chini EN. 2007. The enzyme CD38 (aNADglycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J 21: 3629-3639.
7. Berger SL, Sassone-Corsi P. 2015. Metabolic signaling to chromatin. Cold Spring Harb Perspect Biol 8: a019463.
8. Berger F, Lau C, Ziegler M. 2007. Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclearNADbiosynthetic enzymeNMNadenylyl transferase 1. Proc Natl Acad Sci 104: 3765-3770.
9. Bheda P, Jing H, Wolberger C, Lin H. 2016. The substrate specificity of sirtuins. Annu Rev Biochem 85: 405-429.
10. Bieging KT, Mello SS, Attardi LD. 2014. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14: 359-370.
11. Bird A. 2007. Perceptions of epigenetics. Nature 447: 396-398.
12. Birney E, Smith GD, Greally JM. 2016. Epigenome-wide association studies and the interpretation of disease -Omics. PLoS Genet 12: e1006105.
13. Bock FJ, Todorova TT, Chang P. 2015. RNA regulation by poly (ADP-ribose) polymerases. Mol Cell 58: 959-969.
14. Boffa LC, Vidali G, Mann RS, Allfrey VG. 1978. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 253: 3364-3366.
15. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, et al. 2007. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11: 37-51.
16. Boukouris AE, Zervopoulos SD, Michelakis ED. 2016. Metabolic enzymes moonlighting in the nucleus: metabolic regulation of gene transcription. Trends Biochem Sci 41: 712-730.
17. Briscoe J, Thérond PP. 2013. The mechanisms of Hedgehog signaling and its roles in development and disease. Nat Rev Mol Cell Biol 14: 416-429.
18. Bungard D, Fuerth BJ, Zeng PY, Faubert B, Maas NL, Viollet B, Carling D, Thompson CB, Jones RG, Berger SL. 2010. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 329: 1201-1205.
19. Burkewitz K, Zhang Y, Mair WB. 2014. AMPK at the nexus of energetic and aging. Cell Metab 20: 10-25.
20. Cai L, Sutter BM, Li B, Tu BP. 2011. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol Cell 42: 426-437.
21. Camacho-Pereira J, Tarragó MG, Chini CC, Nin V, Escande C, Warner GM, Puranik AS, Schoon RA, Reid JM, Galina A, et al. 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab 23: 1127-1139.
22. Cambronne XA, Stewart ML, Kim D, Jones-Brunette AM, Morgan RK, Farrens DL, Cohen MS, Goodman RH. 2016. Biosensor reveals multiple sources for mitochondrial NAD+. Science 352: 1474-1477.
23. Campbell KJ, White RJ. 2014. MYC regulation of cell growth through control of transcription by RNA polymerases I and III. Cold Spring Harb Perspect Med 4: a018408.
24. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-1060.
25. Cantó C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR, Auwerx J. 2010. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11: 213-219.
26. Cantó C, Menzies KJ, Auwerx J. 2015. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab 22: 31-53.
27. Carey BW, Finley LW, Cross JR, Allis CD, Thompson CB. 2015. Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518: 413-416.
28. Castello A, Hentze MW, Preiss T. 2015. Metabolic enzymes enjoying new partnerships as RNA-binding proteins. Trends Endocrinol Metab 26: 746-757.
29. Chalkiadaki A, Guarente L. 2015. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer 15: 608-624.
30. Chaneton B, Hillmann P, Zheng L, Martin AC, Maddocks OD, Chokkathukalam A, Coyle JE, Jankevics A, Holding FP, Vousden KH, et al. 2012. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491: 458-462.
31. Chang C, Su H, Zhang D, Wang Y, Shen Q, Liu B, Huang R, Zhou T, Peng C, Wong CC, et al. 2015. AMPK-dependent phosphorylation of GAPDH triggers Sirt1 activation and is necessary for autophagy upon glucose starvation. Mol Cell 60: 930-940.
32. Chen Y, Sprung R, Tang Y, Ball H, Sangras B, Kim SC, Falck JR, Peng J, Gu W, Zhao Y. 2007. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol Cell Proteomics 6: 812-819.
33. Chen D, Bruno J, Easlon E, Lin SJ, Cheng HL, Alt FW, Guarente L. 2008. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev 22: 1753-1757.
34. Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, Leung IK, Li XS, Woon EC, Yang M, et al. 2011. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 12: 463-469.
35. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. 2008. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233.
36. Coloff JL, Murphy JP, Braun CR, Harris IS, Shelton LM, Kami K, Gygi SP, Selfors LM, Brugge JS. 2016. Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells. Cell Metab 23: 867-880.
37. Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, Walters H, Tantawy MN, Fu A, Manning HC, et al. 2014. Acetate dependence of tumors. Cell 159: 1591-1602.
38. Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B. 2004. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428: 486.
39. Dai RP, Yu FX, Goh SR, Chng HW, Tan YL, Fu JL, Zheng L, Luo Y. 2008. Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status. J Biol Chem 283: 26894-26901.
40. Dang CV, Lewis BC. 1997. Role of oncogenic transcription factor c-Myc in cell cycle regulation, apoptosis and metabolism. J Biomed Sci 4: 269-278.
41. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-744.
42. Daxinger L, Whitelaw E. 2012. Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat Rev Genet 13: 153-162.
43. Day CR, Kempson SA. 2016. Betaine chemistry, roles, and potential use in liver disease. Biochim Biophys Acta 1860: 1098-1106.
44. DeBerardinis RJ. 2016. Proliferating cells conserve nitrogen to support growth. Cell Metab 23: 957-958.
45. Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. 1999. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399: 491-496.
46. Ding W, Smulan LJ, Hou NS, Taubert S, Watts JL, Walker AK. 2015. S-Adenosylmethionine levels govern innate immunity through distinct methylation-dependent pathways. Cell Metab 22: 633-645.
47. Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. 2012. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 48: 612-626.
48. Ducker GS, Chen L, Morscher RJ, Ghergurovich JM, Esposito M, Teng X, Kang Y, Rabinowitz JD. 2016. Reversal of cytosolic one-carbon flux compensates for loss of the mitochondrial folate pathway. Cell Metab 23: 1140-1153.
49. Evans RM, Mangelsdorf DJ. 2014. Nuclear receptors, RXR, and the big bang. Cell 157: 255-266.
50. Evertts AG, Zee BM, Dimaggio PA, Gonzales-Cope M, Coller HA, Garcia BA. 2013. Quantitative dynamics of the link between cellular metabolism and histone acetylation. J Biol Chem 288: 12142-12151.
51. Faesen AC, Dirac AM, Shanmugham A, Ovaa H, Perrakis A, Sixma TK. 2011. Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol Cell 44: 147-159.
52. Feldman JL, Baeza J, Denu JM. 2013. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J Biol Chem 288: 31350-31356.
53. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. 2010. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18: 553-567.
54. Filippakopoulos P, Knapp S. 2014. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov 13: 337-356.
55. Frappier L, Verrijzer CP. 2011. Gene expression control by protein deubiquitinases. Curr Opin Genet Dev 21: 207-213.
56. Friis RM, Wu BP, Reinke SN, Hockman DJ, Sykes BD, Schultz MC. 2009. A glycolytic burst drives glucose induction of global histone acetylation by picNuA4 and SAGA. Nucleic Acids Res 37: 3969-3980.
57. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14: 661-673.
58. Gao X, Wang H, Yang JJ, Liu X, Liu ZR. 2012. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598-609.
59. Garten A, Schuster S, Penke M, Gorski T, de Giorgis T, Kiess W. 2015. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol 11: 535-546.
60. Gaspar-Maia A, Alajem A, Meshorer E, Ramalho-Santos M. 2011. Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol 12: 36-47.
61. Gibson BA, Kraus WL. 2012. Newinsights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13: 411-424.
62. Gibson BA, Zhang Y, Jiang H, Hussey KM, Shrimp JH, Lin H, Schwede F, Yu Y, Kraus WL. 2016. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. Science 353: 45-50.
63. Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, et al. 2013. DecliningNAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155: 1624-1638.
64. Goudarzi A, Zhang D, Huang H, Barral S, Kwon OK, Qi S, Tang Z, Buchou T, Vitte AL, He T, et al. 2016. Dynamic competing histone H4 K5K8 acetylation and butyrylation are hallmarks of highly active gene promoters. Mol Cell 62: 169-180.
65. Greer EL, Shi Y. 2012. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13: 343-357.
66. Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG, Sasaki M, Jin S, Schenkein DP, Su SM, et al. 2010. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 207: 339-344.
67. Guarente L. 2013. Calorie restriction and sirtuins revisited. Genes Dev 27: 2072-2085.
68. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. 2010. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev 23: 366-384.
69. Guo M, Schimmel P. 2013. Essential nontranslational functions of tRNA synthetases. Nat Chem Biol 9: 145-153.
70. Hales CN, Barker DJ. 2001. The thrifty phenotype hypothesis. Br Med Bull 60: 5-20.
71. Hallows WC, Yu W, Denu JM. 2012. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation. J Biol Chem 287: 3850-3858.
72. Heard E, Martienssen RA. 2014. Transgenerational epigenetic inheritance: myths and mechanisms. Cell 157: 95-109.
73. Hebert AS, Dittenhafer-Reed KE, Yu W, Bailey DJ, Selen ES, Boersma MD, Carson JJ, Tonelli M, Balloon AJ, Higbee AJ, et al. 2013. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 49: 186-199.
74. Hedstrom L. 2009. IMP dehydrogenase: structure, mechanism, and inhibition. Chem Rev 109: 2903-2928.
75. Herranz D, Serrano M. 2010. SIRT1: recent lessons from mouse models. Nat Rev Cancer 10: 819-823.
76. Hirschey MD, Zhao Y. 2015. Metabolic regulation by lysine malonylation, succinylation, and glutarylation. Mol Cell Proteomics 14: 2308-2315.
77. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, et al. 2010. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 121-125.
78. Hock A, Vousden KH. 2010. Regulation of the p53 pathway by ubiquitin and related proteins. Int J Biochem Cell Biol 42: 1618-1621.
79. Horikoshi M, Beaumont RN, Day FR, Warrington NM, Kooijman MN, Fernandez-Tajes J, Feenstra B, van Zuydam NR, Gaulton KJ, Grarup N, et al. 2016. Genome-wide associations for birth weight and correlations with adult disease. Nature 538: 248-252.
80. Hoshino A, Hirst JA, Fujii H. 2007. Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase. J Biol Chem 282: 17706-17711.
81. Hosios AM, Fiske BP, Gui DY, Vander Heiden MG. 2015. Lack of evidence for PKM2 protein kinase activity. Mol Cell 59: 850-857.
82. Hwang IY, Kwak S, Lee S, Kim H, Lee SE, Kim JH, Kim YA, Jeon YK, Chung DH, Jin X, et al. 2016. Psat1-dependent fluctuations in α-ketoglutarate affect the timing of ESC differentiation. Cell Metab 24: 494-501.
83. Imai S, Guarente L. 2014.NAD+and sirtuins in aging and disease. Trends Cell Biol 24: 464-471.
84. Iqbal K, Tran DA, Li AX, Warden C, Bai AY, Singh P, Wu X, Pfeifer GP, Szabó PE. 2015. Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming. Genome Biol 16: 59.
85. Israelsen WJ, Vander Heiden MG. 2015. Pyruvate kinase: function, regulation and role in cancer. Semin Cell Dev Biol 43: 43-51.
86. Israelsen WJ, Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, Li J, Yu Y, Sasaki M, Horner JW, et al. 2013. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155: 397-409.
87. Ito K, Suda T. 2014. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol 15: 243-256.
88. Kaelin WG Jr., McKnight SL. 2013. Influence of metabolism on epigenetics and disease. Cell 153: 56-69.
89. Katoh Y, Ikura T, Hoshikawa Y, Tashiro S, Ito T, Ohta M, Kera Y, Noda T, Igarashi K. 2011. Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein. Mol Cell 41: 554-566.
90. Keith B, Johnson RS, Simon MC. 2011. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12: 9-22.
91. Keller KE, Tan IS, Lee YS. 2012. SAICAR stimulates pyruvate kinase isoformM2 and promotes cancer cell survival in glucoselimited conditions. Science 338: 1069-1072.
92. Kennedy BK, Lamming DW. 2016. The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging. Cell Metab 23: 990-1003.
93. Kera Y, Katoh Y, Ohta M, Matsumoto M, Takano-Yamamoto T, Igarashi K. 2013. Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus. J Biol Chem 288: 13592-13601.
94. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI Jr, Jahromi MS, Xekouki P, et al. 2013. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov 3: 648-657.
95. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-185.
96. Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, Losman JA, Joensuu P, Bergmann U, Gross S, et al. 2012. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483: 484-488.
97. Kooistra SM, Helin K. 2012. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 13: 297-311.
98. Kornberg MD, Sen N, Hara MR, Juluri KR, Nguyen JV, Snowman AM, Law L, Hester LD, Snyder SH. 2010. GAPDH mediates nitrosylation of nuclear proteins. Nat Cell Biol 12: 1094-1100.
99. Koster MJ, Snel B, Timmers HT. 2015. Genesis of chromatin and transcription dynamics in the origin of species. Cell 161: 724-736.
100. Kozhevnikova EN, van der Knaap JA, Pindyurin AV, Ozgur Z, van Ijcken WF, Moshkin YM, Verrijzer CP. 2012. Metabolic enzyme IMPDH is also a transcription factor regulated by cellular state. Mol Cell 47: 133-139.
101. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M, Kraus WL. 2008. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319: 819-821.
102. Kurdistani SK. 2011. Histone modifications in cancer biology and prognosis. Prog Drug Res 67: 91-106.
103. Kurdistani SK. 2014. Chromatin: a capacitor of acetate for integrated regulation of gene expression and cell physiology. Curr Opin Genet Dev 26: 53-58.
104. Labuschagne CF, van den Broek NJ, Mackay GM, Vousden KH, Maddocks OD. 2014. Serine, but not glycine, supports onecarbon metabolism and proliferation of cancer cells. Cell Rep 7: 1248-1258.
105. Laffel L. 1999. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15: 412-426.
106. Laugesen A, Helin K. 2014. Chromatin repressive complexes in stem cells, development, and cancer. Cell Stem Cell 14: 735-751.
107. Lecona E, Narendra V, Reinberg D. 2015. USP7 cooperates with SCML2 to regulate the activity of PRC1. Mol Cell Biol 35: 1157-1168.
108. Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, Worth AJ, Yuan ZF, Lim HW, Liu S, et al. 2014. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab 20: 306-319.
109. Letouzé E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P, et al. 2013. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23: 739-752.
110. Levine M, Cattoglio C, Tjian R. 2014. Looping back to leap forward: transcription enters a new era. Cell 157: 13-25.
111. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W. 2002. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416: 648-653.
112. Li M, Brooks CL, Kon N, Gu W. 2004. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 13: 879-886.
113. Li B, Qiu B, Lee DS, Walton ZE, Ochocki JD, Mathew LK, Mancuso A, Gade TP, Keith B, Nissim I, et al. 2014. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513: 251-255.
114. Li S, Swanson SK, Gogol M, Florens L, Washburn MP, Workman JL, Suganuma T. 2015. Serine and SAM responsive complex SESAME regulates histone modification crosstalk by sensing cellular metabolism. Mol Cell 60: 408-421.
115. Li Y, Sabari BR, Panchenko T, Wen H, Zhao D, Guan H, Wan L, Huang H, Tang Z, Zhao Y, et al. 2016. Molecular coupling of histone crotonylation and active transcription by AF9 YEATS domain. Mol Cell 62: 181-193.
116. Locasale JW. 2013. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13: 572-583.
117. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, et al. 2011. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43: 869-874.
118. Losman JA, Kaelin WG Jr. 2013. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev 27: 836-852.
119. Losman JA, Looper RE, Koivunen P, Lee S, Schneider RK, McMahon C, Cowley GS, Root DE, Ebert BL, KaelinWGJr. 2013. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339: 1621-1625.
120. Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, et al. 2012. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483: 474-478.
121. Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389: 251-260.
122. Luo W, Hu H, Chang R, Zhong J, Knabel M, O’Meally R, Cole RN, Pandey A, Semenza GL. 2011. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732-744.
123. Lupton JR. 2004. Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr 134: 479-482.
124. Maddocks OD, Labuschagne CF, Adams PD, Vousden KH. 2016. Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol Cell 61: 210-221.
125. Maertens GN, El Messaoudi-Aubert S, Elderkin S, Hiom K, Peters G. 2010. Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBOJ. 29: 2553-2565.
126. Majmundar AJ, Wong WJ, Simon MC. 2010. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40: 294-309.
127. Mariño G, Pietrocola F, Eisenberg T, Kong Y, Malik SA, Andryushkova A, Schroeder S, Pendl T, Harger A, Niso-Santano M, et al. 2014. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol Cell 53: 710-725.
128. Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, Nannepaga S, Piccirillo SG, Kovacs Z, Foong C, et al. 2014. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159: 1603-1614.
129. Masliah-Planchon J, Bièche I, Guinebretière JM, Bourdeaut F, Delattre O. 2015. SWI/SNF chromatin remodeling and human malignancies. Annu Rev Pathol 10: 145-171.
130. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. 2012. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One 7: e42357.
131. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. 2005. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15: 300-308.
132. McBrian MA, Behbahan IS, Ferrari R, Su T, Huang TW, Li K, Hong CS, Christofk HR, Vogelauer M, Seligson DB, et al. 2013. Histone acetylation regulates intracellular pH. Mol Cell 49: 310-321.
133. Mentch SJ, Mehrmohamadi M, Huang L, Liu X, Gupta D, Mattocks D, Gómez Padilla P, Ables G, Bamman MM, Thalacker-Mercer AE, et al. 2015. Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Cell Metab 22: 861-873.
134. Menzies KJ, Zhang H, Katsyuba E, Auwerx J. 2016. Protein acetylation in metabolism—metabolites and cofactors. Nat Rev Endocrinol 12: 43-60.
135. Morgan MA, Shilatifard A. 2015. Chromatin signatures of cancer. Genes Dev 29: 238-249.
136. Mortimer SE, Xu D, McGrew D, Hamaguchi N, Lim HC, Bowne SJ, Daiger SP, Hedstrom L. 2008. IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA. J Biol Chem 283: 36354-36360.
137. Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cantó C, Mottis A, Jo YS, Viswanathan M, Schoonjans K, et al. 2013. The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154: 430-441.
138. Moussaieff A, Rouleau M, Kitsberg D, Cohen M, Levy G, Barasch D, Nemirovski A, Shen-Orr S, Laevsky I, Amit M, et al. 2015. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab 21: 392-402.
139. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. 2009. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324: 654-657.
140. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197.
141. Patel DJ, Wang Z. 2013. Readout of epigenetic modifications. Annu Rev Biochem 82: 81-118.
142. Peleg S, Feller C, Forne I, Schiller E, Sévin DC, Schauer T, Regnard C, Straub T, Prestel M, Klima C, et al. 2016. Life span extension by targeting a link between metabolism and histoneacetylation in Drosophila. EMBO Rep 17: 455-469.
143. Pengelly AR, Copur Ö, Jäckle H, Herzig A, Müller J. 2013. A histone mutant reproduces the phenotype caused by loss of histone-modifying factor Polycomb. Science 339: 698-699.
144. Petesch SJ, Lis JT. 2012. Activator-induced spread of poly(ADP-ribose) polymerase promotes nucleosome loss at Hsp70. Mol Cell 45: 64-74.
145. Ptashne M. 2007. On the use of the word ‘epigenetic’. Curr Biol 17: R233-R236.
146. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. 2008. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19: 65-73.
147. Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C, et al. 2009. Circadian clock feedback cycle through NAMPT-mediated NAD + biosynthesis. Science 324: 651-654.
148. Rando OJ, Simmons RA. 2015. I’meating for two: parental dietary effects on offspring metabolism. Cell 161: 93-105.
149. Rasmussen KD, Helin K. 2016. Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev 30: 733-750.
150. Reddy BA, van der Knaap JA, Bot AG, Mohd-Sarip A, Dekkers DH, Timmermans MA, Martens JW, Demmers JA, Verrijzer CP. 2014. Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization. Mol Cell 53: 458-470.
151. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434: 113-118.
152. Rohle D, Popovici-Muller J, Palaskas N, Turcan S, Grommes C, Campos C, Tsoi J, Clark O, Oldrini B, Komisopoulou E, et al. 2013. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 340: 626-630.
153. Ryall JG, Cliff T, Dalton S, Sartorelli V. 2015a. Metabolic reprogramming of stem cell epigenetics. Cell Stem Cell 17: 651-662.
154. Ryall JG, Dell’Orso S, Derfoul A, Juan A, Zare H, Feng X, Clermont D, Koulnis M, Gutierrez-Cruz G, Fulco M, et al. 2015b. The NAD+-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 16: 171-183.
155. Sabari BR, Tang Z, Huang H, Yong-Gonzalez V, Molina H, Kong HE, Dai L, Shimada M, Cross JR, Zhao Y, et al. 2015. Intracellular crotonyl-CoA stimulates transcription through p300 catalyzed histone crotonylation. Mol Cell 58: 203-215.
156. Sadhu MJ, Guan Q, Li F, Sales-Lee J, Iavarone AT, Hammond MC, Cande WZ, Rine J. 2013. Nutritional control of epigenetic processes in yeast and human cells. Genetics 195: 831-844.
157. Sainsbury S, Bernecky C, Cramer P. 2015. Structural basis of transcription initiation by RNA polymerase II. Nat Rev Mol Cell Biol 16: 129-143.
158. Sanchez R, Zhou MM. 2009. The role of human bromodomains in chromatin biology and gene transcription. Curr Opin Drug Discov Devel 12: 659-665.
159. Sarkari F, Sanchez-Alcaraz T, Wang S, Holowaty MN, Sheng Y, Frappier L. 2009. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog 5: e1000624.
160. Schübeler D. 2015. Function and information content of DNA methylation. Nature 517: 321-326.
161. Schug ZT, Peck B, Jones DT, Zhang Q, Grosskurth S, Alam IS, Goodwin LM, Smethurst E, Mason S, Blyth K, et al. 2015. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27: 57-71.
162. Schulz LC. 2010. The Dutch HungerWinter and the developmental origins of health and disease. Proc Natl Acad Sci 107: 16757-16758.
163. Sciacovelli M, Gonçalves E, Johnson TI, Zecchini VR, da Costa AS, Gaude E, Drubbel AV, Theobald SJ, Abbo SR, Tran MG, et al. 2016. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537: 544-547.
164. Sealy L, Chalkley R. 1978. The effect of sodium butyrate on histone modification. Cell 14: 115-121.
165. Sen N, Hara MR, Kornberg MD, Cascio MB, Bae BI, Shahani N, Thomas B, Dawson TM, Dawson VL, Snyder SH, et al. 2008. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 10: 866-873.
166. Shea JM, Serra RW, Carone BR, Shulha HP, Kucukural A, Ziller MJ, Vallaster MP, Gu H, Tapper AR, Gardner PD, et al. 2015. Genetic and epigenetic variation, but not diet, shape the sperm methylome. Dev Cell. 35: 750-758.
167. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119: 941-953.
168. Shilatifard A. 2012. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem 81: 65-95.
169. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, et al. 2013. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339: 211-214.
170. Shiraki N, Shiraki Y, Tsuyama T, Obata F, Miura M, Nagae G, Aburatani H, Kume K, Endo F, Kume S. 2014. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab 19: 780-794.
171. Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL. 2006. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311: 844-847.
172. Shyh-Chang N, Locasale JW, Lyssiotis CA, Zheng Y, Teo RY, Ratanasirintrawoot S, Zhang J, Onder T, Unternaehrer JJ, Zhu H, et al. 2013. Influence of threonine metabolism on Sadenosylmethionine and histone methylation. Science 339: 222-226.
173. Smithells D. 1998. Does thalidomide cause second generation birth defects? Drug Safety 19: 339-341.
174. Strömland K, Philipson E, Andersson Grönlund M. 2002. Offspring of male and female parents with thalidomide embryopathy: birth defects and functional anomalies. Teratology 66: 115-121.
175. Sutendra G, Kinnaird A, Dromparis P, Paulin R, Stenson TH, Haromy A, Hashimoto K, Zhang N, Flaim E, Michelakis ED. 2014. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 158: 84-97.
176. Swygert SG, Peterson CL. 2014. Chromatin dynamics: interplay between remodeling enzymes and histone modifications. Biochim Biophys Acta 1839: 728-736.
177. Takahashi H, McCaffery JM, Irizarry RA, Boeke JD. 2006. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol Cell 23: 207-217.
178. Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, Buchou T, Cheng Z, Rousseaux S, Rajagopal N, et al. 2011. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146: 1016-1028.
179. Tennessen JM, Baker KD, Lam G, Evans J, Thummel CS. 2011. The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth. Cell Metab 13: 139-148.
180. Tennessen JM, Bertagnolli NM, Evans J, Sieber MH, Cox J, Thummel CS. 2014. Coordinated metabolic transitions during Drosophila embryogenesis and the onset of aerobic glycolysis. G3 (Bethesda) 4: 839-850.
181. TeSlaa T, Chaikovsky AC, Lipchina I, Escobar SL, Hochedlinger K, Huang J, Graeber TG, Braas D, Teitell MA. 2016. α-Ketoglutarate accelerates the initial differentiation of primed human pluripotent stem cells. Cell Metab 24: 485-493.
182. Tibbetts AS, Appling DR. 2010. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr 30: 57-81.
183. Tong X, Zhao F, Thompson CB. 2009. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 19: 32-37.
184. Towbin BD, González-Aguilera C, Sack R, Gaidatzis D, Kalck V, Meister P, Askjaer P, Gasser SM. 2012. Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell 150: 934-947.
185. Toyota M, Issa JP. 1999. CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 9: 349-357.
186. Tristan C, Shahani N, Sedlak TW, Sawa A. 2011. The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal 23: 317-323.
187. Tsuchiya Y, Pham U, Hu W, Ohnuma S, Gout I. 2014. Changes in acetyl CoA levels during the early embryonic development of Xenopus laevis. PLoS One 9: e97693.
188. Tu BP, Kudlicki A, Rowicka M, McKnight SL. 2005. Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes. Science 310: 1152-1158.
189. Tulin A, Spradling A. 2003. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 299: 560-562.
190. Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS, et al. 2012. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483: 479-483.
191. van der Knaap JA, Kumar BR, Moshkin YM, Langenberg K, Krijgsveld J, Heck AJ, Karch F, Verrijzer CP. 2005. GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol Cell 17: 695-707.
192. van der Knaap JA, Kozhevnikova E, Langenberg K, Moshkin YM, Verrijzer CP. 2010. Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes. Mol Cell Biol 30: 736-744.
193. Venkatesh S, Workman JL. 2015. Histone exchange, chromatin structure and the regulation of transcription. Nat Rev Mol Cell Biol 16: 178-189.
194. Verdin E. 2015. NAD+ in aging, metabolism, and neurodegeneration. Science 350: 1208-1213.
195. Walport LJ, Hopkinson RJ, Schofield CJ. 2012. Mechanisms of human histone and nucleic acid demethylases. Curr Opin Chem Biol 16: 525-534.
196. Wang J, Alexander P, Wu L, Hammer R, Cleaver O, McKnight SL. 2009. Dependence of mouse embryonic stem cells on threonine catabolism. Science 325: 435-439.
197. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, et al. 2010. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17: 225-234.
198. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. 2009. ATP-citrate lyase links cellular metabolism o histone acetylation. Science 324: 1076-1080.
199. Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, Liu L, Liu Y, Yang C, Xu Y, et al. 2012. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26: 1326-138.
200. Xie Z, Zhang D, Chung D, Tang Z, Huang H, Dai L, Qi S, Li J, Colak G, Chen Y, et al. 2016. Metabolic regulation of gene expression by histone lysine β-hydroxybutyrylation. Mol Cell 62: 194-206.
201. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT, et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19: 17-30.
202. Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A, et al. 2007. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130: 1095-1107.
203. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K, Lu Z. 2011. Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 480: 118-122.
204. Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK, Lu Z. 2012. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150: 685-696.
205. Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, Thompson CB. 2012. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci 109: 6904-6909.
206. Yoshino J, Mills KF, Yoon MJ, Imai S. 2011. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14: 528-536.
207. Zentner GE, Henikoff S. 2013. Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 20: 259-266.
208. Zhai RG, Zhang F, Hiesinger PR, Cao Y, Haueter CM, Bellen HJ. 2008. NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration. Nature 452: 887-891.
209. Zhang Q, Piston DW, Goodman RH. 2002. Regulation of corepressor function by nuclear NADH. Science 295: 1895-1897.
210. Zhang T, Berrocal JG, Yao J, DuMond ME, Krishnakumar R, Ruhl DD, Ryu KW, Gamble MJ, Kraus WL. 2012. Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+synthase. J Biol Chem 287: 12405-12416.
211. Zheng L, Roeder RG, Luo Y. 2003. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 114: 255-266.
212. Zhou Z, Yao X, Li S, Xiong Y, Dong X, Zhao Y, Jiang J, Zhang Q. 2015. Deubiquitination of Ci/Gli by Usp7/HAUSP regulates hedgehog signaling. Dev Cell 34: 58-72.